nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA9—cervical cancer	0.847	1	CbGaD
Topiramate—CA6—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0069	0.115	CbGpPWpGaD
Topiramate—CA5A—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0069	0.115	CbGpPWpGaD
Topiramate—GRIK4—renal system—cervical cancer	0.00664	0.103	CbGeAlD
Topiramate—CA7—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00644	0.108	CbGpPWpGaD
Topiramate—CA5B—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00644	0.108	CbGpPWpGaD
Topiramate—CA12—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00597	0.0998	CbGpPWpGaD
Topiramate—CA6—exocrine gland—cervical cancer	0.00566	0.0878	CbGeAlD
Topiramate—CA4—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00476	0.0796	CbGpPWpGaD
Topiramate—CA2—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00456	0.0763	CbGpPWpGaD
Topiramate—GRIK3—mammalian vulva—cervical cancer	0.00453	0.0703	CbGeAlD
Topiramate—CA1—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00437	0.0732	CbGpPWpGaD
Topiramate—GRIK3—female reproductive system—cervical cancer	0.00388	0.0602	CbGeAlD
Topiramate—GRIK3—vagina—cervical cancer	0.00351	0.0544	CbGeAlD
Topiramate—GRIK1—female gonad—cervical cancer	0.00335	0.052	CbGeAlD
Topiramate—GRIK1—vagina—cervical cancer	0.00333	0.0517	CbGeAlD
Topiramate—CA5A—female reproductive system—cervical cancer	0.00284	0.0441	CbGeAlD
Topiramate—GRIA1—Mecp2 and Associated Rett Syndrome—POU4F1—cervical cancer	0.00266	0.0445	CbGpPWpGaD
Topiramate—CA7—renal system—cervical cancer	0.00236	0.0366	CbGeAlD
Topiramate—GRIK5—lymph node—cervical cancer	0.00227	0.0352	CbGeAlD
Topiramate—GRIK3—lymph node—cervical cancer	0.00227	0.0352	CbGeAlD
Topiramate—CA2—exocrine gland—cervical cancer	0.00195	0.0302	CbGeAlD
Topiramate—CA9—female reproductive system—cervical cancer	0.00166	0.0257	CbGeAlD
Topiramate—CA12—renal system—cervical cancer	0.00153	0.0238	CbGeAlD
Topiramate—CA1—C-MYB transcription factor network—PIAS3—cervical cancer	0.00149	0.025	CbGpPWpGaD
Topiramate—CA5B—mammalian vulva—cervical cancer	0.00128	0.0199	CbGeAlD
Topiramate—CA12—female reproductive system—cervical cancer	0.00123	0.019	CbGeAlD
Topiramate—CA1—renal system—cervical cancer	0.00121	0.0188	CbGeAlD
Topiramate—CA5B—female reproductive system—cervical cancer	0.0011	0.0171	CbGeAlD
Topiramate—Rash erythematous—Topotecan—cervical cancer	0.00108	0.0374	CcSEcCtD
Topiramate—Rigors—Topotecan—cervical cancer	0.00101	0.0351	CcSEcCtD
Topiramate—CA5B—vagina—cervical cancer	0.000995	0.0154	CbGeAlD
Topiramate—CA1—female reproductive system—cervical cancer	0.000972	0.0151	CbGeAlD
Topiramate—SCN5A—vagina—cervical cancer	0.000964	0.015	CbGeAlD
Topiramate—CA4—renal system—cervical cancer	0.000948	0.0147	CbGeAlD
Topiramate—Dysmenorrhoea—Topotecan—cervical cancer	0.000909	0.0315	CcSEcCtD
Topiramate—Bone pain—Topotecan—cervical cancer	0.000863	0.0299	CcSEcCtD
Topiramate—CA2—epithelium—cervical cancer	0.000848	0.0132	CbGeAlD
Topiramate—Pulmonary embolism—Topotecan—cervical cancer	0.000826	0.0286	CcSEcCtD
Topiramate—CA2—decidua—cervical cancer	0.000801	0.0124	CbGeAlD
Topiramate—CA2—renal system—cervical cancer	0.000786	0.0122	CbGeAlD
Topiramate—Neuropathy—Topotecan—cervical cancer	0.000776	0.0269	CcSEcCtD
Topiramate—CA4—female reproductive system—cervical cancer	0.00076	0.0118	CbGeAlD
Topiramate—Rash maculo-papular—Topotecan—cervical cancer	0.000751	0.026	CcSEcCtD
Topiramate—Neoplasm—Topotecan—cervical cancer	0.000747	0.0259	CcSEcCtD
Topiramate—CA2—mammalian vulva—cervical cancer	0.000735	0.0114	CbGeAlD
Topiramate—Ear pain—Topotecan—cervical cancer	0.000703	0.0243	CcSEcCtD
Topiramate—CA4—female gonad—cervical cancer	0.000691	0.0107	CbGeAlD
Topiramate—CA5B—lymph node—cervical cancer	0.000644	0.00999	CbGeAlD
Topiramate—CA2—female reproductive system—cervical cancer	0.00063	0.00977	CbGeAlD
Topiramate—CYP2C19—vagina—cervical cancer	0.000622	0.00965	CbGeAlD
Topiramate—Lethargy—Topotecan—cervical cancer	0.000612	0.0212	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—INSM1—cervical cancer	0.000581	0.00971	CbGpPWpGaD
Topiramate—CA2—female gonad—cervical cancer	0.000573	0.00889	CbGeAlD
Topiramate—CA2—vagina—cervical cancer	0.00057	0.00884	CbGeAlD
Topiramate—CA1—lymph node—cervical cancer	0.000568	0.00882	CbGeAlD
Topiramate—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00054	0.0187	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000529	0.0183	CcSEcCtD
Topiramate—CYP3A4—renal system—cervical cancer	0.000507	0.00787	CbGeAlD
Topiramate—Pancytopenia—Topotecan—cervical cancer	0.000492	0.0171	CcSEcCtD
Topiramate—Neutropenia—Topotecan—cervical cancer	0.000485	0.0168	CcSEcCtD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.000477	0.00797	CbGpPWpGaD
Topiramate—Weight increased—Topotecan—cervical cancer	0.000472	0.0163	CcSEcCtD
Topiramate—Pneumonia—Topotecan—cervical cancer	0.000465	0.0161	CcSEcCtD
Topiramate—Infestation—Topotecan—cervical cancer	0.000462	0.016	CcSEcCtD
Topiramate—Infestation NOS—Topotecan—cervical cancer	0.000462	0.016	CcSEcCtD
Topiramate—Neuropathy peripheral—Topotecan—cervical cancer	0.000453	0.0157	CcSEcCtD
Topiramate—Stomatitis—Topotecan—cervical cancer	0.000451	0.0156	CcSEcCtD
Topiramate—CA4—lymph node—cervical cancer	0.000444	0.0069	CbGeAlD
Topiramate—Epistaxis—Topotecan—cervical cancer	0.000436	0.0151	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—HES1—cervical cancer	0.000426	0.00712	CbGpPWpGaD
Topiramate—Haemoglobin—Topotecan—cervical cancer	0.000417	0.0144	CcSEcCtD
Topiramate—Rhinitis—Topotecan—cervical cancer	0.000416	0.0144	CcSEcCtD
Topiramate—Haemorrhage—Topotecan—cervical cancer	0.000415	0.0144	CcSEcCtD
Topiramate—Hypoaesthesia—Topotecan—cervical cancer	0.000413	0.0143	CcSEcCtD
Topiramate—Pharyngitis—Topotecan—cervical cancer	0.000412	0.0143	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—INSM1—cervical cancer	0.000408	0.00682	CbGpPWpGaD
Topiramate—CYP3A4—female reproductive system—cervical cancer	0.000406	0.00631	CbGeAlD
Topiramate—CA9—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000398	0.00665	CbGpPWpGaD
Topiramate—Angiopathy—Topotecan—cervical cancer	0.000376	0.013	CcSEcCtD
Topiramate—Immune system disorder—Topotecan—cervical cancer	0.000375	0.013	CcSEcCtD
Topiramate—Mediastinal disorder—Topotecan—cervical cancer	0.000374	0.013	CcSEcCtD
Topiramate—Chills—Topotecan—cervical cancer	0.000372	0.0129	CcSEcCtD
Topiramate—CA2—lymph node—cervical cancer	0.000368	0.00572	CbGeAlD
Topiramate—Alopecia—Topotecan—cervical cancer	0.000367	0.0127	CcSEcCtD
Topiramate—Malnutrition—Topotecan—cervical cancer	0.000361	0.0125	CcSEcCtD
Topiramate—Back pain—Topotecan—cervical cancer	0.000349	0.0121	CcSEcCtD
Topiramate—Muscle spasms—Topotecan—cervical cancer	0.000347	0.012	CcSEcCtD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—cervical cancer	0.000338	0.00565	CbGpPWpGaD
Topiramate—GRIA2—N-cadherin signaling events—CTNNB1—cervical cancer	0.000336	0.00561	CbGpPWpGaD
Topiramate—Ill-defined disorder—Topotecan—cervical cancer	0.000335	0.0116	CcSEcCtD
Topiramate—Anaemia—Topotecan—cervical cancer	0.000334	0.0116	CcSEcCtD
Topiramate—Malaise—Topotecan—cervical cancer	0.000326	0.0113	CcSEcCtD
Topiramate—Leukopenia—Topotecan—cervical cancer	0.000323	0.0112	CcSEcCtD
Topiramate—Cough—Topotecan—cervical cancer	0.000315	0.0109	CcSEcCtD
Topiramate—Arthralgia—Topotecan—cervical cancer	0.000307	0.0107	CcSEcCtD
Topiramate—Myalgia—Topotecan—cervical cancer	0.000307	0.0107	CcSEcCtD
Topiramate—Chest pain—Topotecan—cervical cancer	0.000307	0.0107	CcSEcCtD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.000306	0.00511	CbGpPWpGaD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000305	0.0106	CcSEcCtD
Topiramate—Discomfort—Topotecan—cervical cancer	0.000304	0.0105	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—MTOR—cervical cancer	0.000298	0.00498	CbGpPWpGaD
Topiramate—Infection—Topotecan—cervical cancer	0.000293	0.0101	CcSEcCtD
Topiramate—Nervous system disorder—Topotecan—cervical cancer	0.000289	0.01	CcSEcCtD
Topiramate—Thrombocytopenia—Topotecan—cervical cancer	0.000289	0.01	CcSEcCtD
Topiramate—Skin disorder—Topotecan—cervical cancer	0.000286	0.00992	CcSEcCtD
Topiramate—Hyperhidrosis—Topotecan—cervical cancer	0.000285	0.00987	CcSEcCtD
Topiramate—Anorexia—Topotecan—cervical cancer	0.000281	0.00973	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—CASP3—cervical cancer	0.000274	0.00458	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000269	0.0093	CcSEcCtD
Topiramate—Paraesthesia—Topotecan—cervical cancer	0.000265	0.00917	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—CTNNB1—cervical cancer	0.000264	0.00442	CbGpPWpGaD
Topiramate—Dyspnoea—Topotecan—cervical cancer	0.000263	0.0091	CcSEcCtD
Topiramate—Dyspepsia—Topotecan—cervical cancer	0.000259	0.00899	CcSEcCtD
Topiramate—Decreased appetite—Topotecan—cervical cancer	0.000256	0.00888	CcSEcCtD
Topiramate—Gastrointestinal disorder—Topotecan—cervical cancer	0.000254	0.00882	CcSEcCtD
Topiramate—Fatigue—Topotecan—cervical cancer	0.000254	0.0088	CcSEcCtD
Topiramate—Pain—Topotecan—cervical cancer	0.000252	0.00873	CcSEcCtD
Topiramate—Constipation—Topotecan—cervical cancer	0.000252	0.00873	CcSEcCtD
Topiramate—Feeling abnormal—Topotecan—cervical cancer	0.000243	0.00841	CcSEcCtD
Topiramate—Gastrointestinal pain—Topotecan—cervical cancer	0.000241	0.00835	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—CD4—cervical cancer	0.000241	0.00402	CbGpPWpGaD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000239	0.004	CbGpPWpGaD
Topiramate—Urticaria—Topotecan—cervical cancer	0.000234	0.00811	CcSEcCtD
Topiramate—Body temperature increased—Topotecan—cervical cancer	0.000233	0.00807	CcSEcCtD
Topiramate—Abdominal pain—Topotecan—cervical cancer	0.000233	0.00807	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00023	0.00385	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—STAT3—cervical cancer	0.00023	0.00385	CbGpPWpGaD
Topiramate—Hypersensitivity—Topotecan—cervical cancer	0.000217	0.00752	CcSEcCtD
Topiramate—Asthenia—Topotecan—cervical cancer	0.000211	0.00733	CcSEcCtD
Topiramate—Pruritus—Topotecan—cervical cancer	0.000209	0.00722	CcSEcCtD
Topiramate—Diarrhoea—Topotecan—cervical cancer	0.000202	0.00699	CcSEcCtD
Topiramate—Dizziness—Topotecan—cervical cancer	0.000195	0.00675	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000189	0.00315	CbGpPWpGaD
Topiramate—Vomiting—Topotecan—cervical cancer	0.000187	0.00649	CcSEcCtD
Topiramate—Rash—Topotecan—cervical cancer	0.000186	0.00644	CcSEcCtD
Topiramate—Dermatitis—Topotecan—cervical cancer	0.000186	0.00643	CcSEcCtD
Topiramate—Headache—Topotecan—cervical cancer	0.000185	0.0064	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—MTOR—cervical cancer	0.000179	0.00299	CbGpPWpGaD
Topiramate—Nausea—Topotecan—cervical cancer	0.000175	0.00606	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—CASP3—cervical cancer	0.000164	0.00275	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CTNNB1—cervical cancer	0.000158	0.00265	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—cervical cancer	0.000157	0.00263	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CA9—cervical cancer	0.00014	0.00234	CbGpPWpGaD
Topiramate—CA6—Metabolism—CA9—cervical cancer	0.00014	0.00234	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—STAT3—cervical cancer	0.000138	0.00231	CbGpPWpGaD
Topiramate—CA7—Metabolism—CA9—cervical cancer	0.000131	0.00219	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CA9—cervical cancer	0.000131	0.00219	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—MTOR—cervical cancer	0.000125	0.00209	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000124	0.00208	CbGpPWpGaD
Topiramate—CA12—Metabolism—CA9—cervical cancer	0.000121	0.00203	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CASP3—cervical cancer	0.000115	0.00192	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CTNNB1—cervical cancer	0.000111	0.00185	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—cervical cancer	0.000111	0.00185	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HES1—cervical cancer	0.000107	0.00178	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CASP3—cervical cancer	9.82e-05	0.00164	CbGpPWpGaD
Topiramate—CA4—Metabolism—CA9—cervical cancer	9.67e-05	0.00162	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—STAT3—cervical cancer	9.65e-05	0.00161	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	9.46e-05	0.00158	CbGpPWpGaD
Topiramate—CA2—Metabolism—CA9—cervical cancer	9.27e-05	0.00155	CbGpPWpGaD
Topiramate—CA1—Metabolism—CA9—cervical cancer	8.89e-05	0.00149	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MTOR—cervical cancer	8.47e-05	0.00142	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NOTCH1—cervical cancer	8.06e-05	0.00135	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HES1—cervical cancer	7.5e-05	0.00125	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—cervical cancer	6.55e-05	0.0011	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—cervical cancer	6.47e-05	0.00108	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	6.23e-05	0.00104	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—cervical cancer	5.94e-05	0.000994	CbGpPWpGaD
Topiramate—CA6—Metabolism—MTHFR—cervical cancer	5.69e-05	0.000952	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—cervical cancer	5.69e-05	0.000952	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NOTCH1—cervical cancer	5.66e-05	0.000947	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—cervical cancer	5.35e-05	0.000895	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—cervical cancer	5.31e-05	0.000888	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—cervical cancer	5.31e-05	0.000888	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—cervical cancer	5e-05	0.000836	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—cervical cancer	4.92e-05	0.000823	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—cervical cancer	4.67e-05	0.00078	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—cervical cancer	4.24e-05	0.000709	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—cervical cancer	4.18e-05	0.000699	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—cervical cancer	3.92e-05	0.000656	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—cervical cancer	3.76e-05	0.000629	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—cervical cancer	3.76e-05	0.000629	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—cervical cancer	3.61e-05	0.000603	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—cervical cancer	3.28e-05	0.000548	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—cervical cancer	3.17e-05	0.00053	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—cervical cancer	2.98e-05	0.000498	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA9—cervical cancer	2.19e-05	0.000366	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA9—cervical cancer	1.32e-05	0.00022	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—cervical cancer	8.88e-06	0.000148	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—cervical cancer	5.34e-06	8.93e-05	CbGpPWpGaD
